Determination of hepatitis C genotype is often required to select the most appropriate direct acting agent(s) (DAA) for the treatment of hepatitis C. Some DAA's are only effective for the treatment of hepatitis C genotype 1, whereas others may be used for additional genotypes. Refer to the package inserts of the relevant DAA's for guidance. A concurrent patient HCV viral load of >=300 IU/mL is required for this test.
* This volume does not allow for repeat testing
Centrifuge at 800-1600 x g for 20 minutes at room temperature
Separate plasma within 24 hours of collection
Transfer the plasma to a properly identified, sterile, polypropylene screw-cap vial
Unspun specimen
Specimen on cells for >24 hours
Heparinized samples
Transport in cold packs
See Laboratory Report
Determination of hepatitis C genotype is often required to select the most appropriate direct acting agent(s) (DAA) for the treatment of hepatitis C. Some DAA's are only effective for the treatment of hepatitis C genotype 1, whereas others may be used for additional genotypes. Refer to the package inserts of the relevant DAA's for guidance. A concurrent patient HCV viral load of >=300 IU/mL is required for this test.
2 to 5 days
00917109
87902